Trial of potential Covid-19 treatment begins in SA
Scientists will determine if the anti-diarrhoea drug nitazoxanide improves outcomes in high-risk patients
27 August 2020 - 19:15
Scientists at Cape Town’s Groote Schuur Hospital have begun enrolling volunteers in a phase 3 trial investigating the potential of the drug nitazoxanide to treat Covid-19.
It is one of several drugs scientists hope to repurpose for treating patients infected with Sars-Cov-2, the virus that causes Covid-19...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.